ClinicalTrials.Veeva

Menu

Comparison of Multiparametric Prostate MRI and Ga-68 PSMA PET Imaging in Prostate Cancer Staging

G

Gulhane Training and Research Hospital

Status

Enrolling

Conditions

Prostate Cancer Stage
Prostate Cancer

Treatments

Diagnostic Test: Multiparametric Prostate MRI

Study type

Interventional

Funder types

Other

Identifiers

NCT05427864
GULHANEUROCANSICIMLI001

Details and patient eligibility

About

In this study, it is aimed to compare the lesion location, lesion size, local and distant metastases detection rates of Ga68 PSMA PET and Multiparametric Prostate MR imaging tests used in staging in patients diagnosed with prostate cancer.

The pathologies of the patients who were decided to undergo radical prostatectomy as a treatment will also be compared with the staging tests.

Enrollment

47 estimated patients

Sex

Male

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosed with prostate cancer
  • Gleason score 7 or above / 6 with high risk
  • No other treatment

Exclusion criteria

  • treated with radiotherapy
  • treated with ADT

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Central trial contact

Can Sicimli, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems